Heroin & Opioids
| Thursday, September 1, 2022 |
| 12:00 AM - 11:00 PM |
| Digital Posters |
Speaker
Dr Katherine Senior
Addiction Medicine Advanced Trainee
Drug & Alcohol Services SA
Iatrogenic Opioid Overdose in an Opioid-Naïve Person Given High-Dose Long-Acting Injectable Buprenorphine
Biography
Dr Senior is an Addiction Medicine Advanced Trainee with a passion for harm reduction including take-home naloxone, supervised injecting centres, pill testing and managed alcohol programs. She is a Fellow of the Royal Australian College of General Practitioners and works full-time with Drug & Alcohol Services SA.
A/Prof Mark Daglish
Director Of Addiction Psychiatry
Metro North Alcohol & Drug Service
Increased Cytochrome P450-2D6 activity in people with codeine use disorders.
Biography
A/Prof Mark Daglish has been Director of Addiction Psychiatry, Royal Brisbane & Women's Hospital since 2007. He is also a staff specialist in one of the city centre opioid replacement clinics in Brisbane and Associate Professor in Addiction Psychiatry at the University of Queensland.
Dr Gary Chan
Research Fellow
National Centre For Youth Substance Use Research
Non-medical use of pharmaceutical opioids with other illicit substance in Australia
Biography
Dr. Gary Chan is a NHMRC Emerging Leadership Fellow at the National Centre for Youth Substance Use Research. His principal research interest lies in the field of substance misuse prevention and the application of cutting-edge statistical method for longitudinal analysis and causal inference.
Dr. Thomas Santo Jr
Post-Doctoral Research Fellow
NDARC, UNSW Sydney
Associations with childhood trauma and comorbid mental disorders among people with opioid dependence
Biography
Tom(he/him/his) is a Ph.D. candidate who is interested in the impact of childhood trauma & mental disorders among people with opioid use disorder. The ultimate goal of his work is to help improve treatment options and reduce the harms among people with opioid use and disorder. Twitter: @tomsantojr
Ms Olya Ryjenko
Research Affiliate
Edith Collins Centre
Capturing key regulatory activities targeting pharmaceutical opioids in Australia: What has the last decade of policy looked like?
Biography
Olya completed a Master of Public Health in 2021, with her Capstone project focusing on extra-medical opioid use and changes in pharmaceutical opioid control policies in Australia. Olya has a clinical research background in the discipline of speech pathology, specialising in the management of stuttering for children, adolescents and adults.
Miss Laura Johnston
Head Of Medical Affairs
Indivior
Long-term recovery from opioid use disorder: identification of recovery subgroups and their association with opioid use, treatment, and quality of life
Biography
Laura Johnston is Head of Medical Affairs for AustralAsia, Indivior Pty, Ltd based in Sydney. She has worked at Indivior for 5 years.
Miss Laura Johnston
Head Of Medical Affairs
Indivior
Dr Anthony Solomon
GP
NCMC Byron Bay
Comparison of Depot Buprenorphine versus Oral Opiate treatment in opiate dependent patients in Rural General Practice – a medical record audit of patient self-reported clinical and quality of life outcomes.
Biography
Anthony Solomon is a General Practitioner and Addiction Medicine advanced trainee. Anthony works at NCMC Byron Bay, Byron Central Hospital and the Byron Private Treatment Centre. He has a casual academic appointment with the University of Sydney and teaches Addiction Medicine to undergraduates at the UCRH in Lismore.
